Education Level as a Predictor of Survival in Patients with Multiple MyelomaLimei Xu(Sun Yat-sen University), Juan Li(Sun Yat-sen University)Research SquareJune 23, 202010.21203/rs.3.rs-18271/v2Cited by 4SaveCiteExport RISWatch citationsRelated PapersFirst-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial|The Lancet Oncology|2025|10